pharmaphorum

FEBRUARY 21, 2022

AZ and Daiichi Sankyo are only releasing the top-line results for now, but said the drug demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) when compared to physicians’ choice of chemo – regardless of patients’ HER2 status.

Chemotherapy 132

Chemotherapy Labelling 132

pharmaphorum

JANUARY 22, 2021

The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions. New research from CRA shows that for many physician practices, prescribing has shifted based on route of administration.

Specialty Pharmacies 98

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

MARCH 11, 2021

Now, artificial intelligence (AI) techniques such as natural language processing (NLP) and machine learning are helping clinicians unlock the data from this valuable, unstructured (free-text) information. They will describe how the research ecosystem is embracing AI, Big Data and Deep RWE and addressing its challenges and opportunities.

102

102

pharmaphorum

MARCH 25, 2022

In January, PLOS Digital Health published a study which claimed that there’s “sparse” data to support the efficacy of most mental health apps. The FDA views wellness apps as akin to over-the-counter homeopathic treatments—products with minimal risks and low potency – and they are unregulated. Consistent Standards Matter.

112

112

Eye on FDA

APRIL 28, 2023

The agency notes that prior research had indicated that the most influential endorsements to lead to purchase intentions were by physicians or pharmacists, followed by consumer endorsements and in last place, celebrity endorsements. The new research effort will look at actual-use disclosures in the medium of television advertising.

Communication 96

Communication 96

pharmaphorum

AUGUST 24, 2020

With our understanding of cancer accelerating at an unprecedented rate, and personalised medicines on the cusp of becoming mainstream, regulatory bodies need new ways to assess products. . Said the team behind the portal: “The aim is to show patient-reported symptom data consistently from select cancer clinical trials of approved products.

Labelling 127

Labelling Communication Drug Development 127

Putting Patients First Blog

APRIL 11, 2023

There are many other research projects in play that will also offer important data to help us create better criteria to accurately diagnose and treat the disease. Variability in symptoms across the patient population can make it challenging for patients and their physicians to manage the disease. Learn about Sjögren’s clinical trials.

Immunity 98

Immunity Immunization 98

pharmaphorum

MAY 17, 2021

In the following, we summarise the situation one year on from the pandemic with updated quantitative data, and qualitative research with physicians in Europe, to bring the all-important ‘voice of the customer’ to the debate around ‘what next?’. The HCP View. Specialist physician, UK. “We Specialist physician, Italy.

Communication 56

Communication 56

The Happy PharmD

OCTOBER 25, 2023

My staff always felt that these meetings were quite productive. The clinical pharmacist presented many detailed pages of data in which medications and their therapies were compared. They are not productive at all! I also stopped the discussion when I felt it was no longer productive. Other times, everyone just vented.

Hospitals 52

Hospitals Pharmacy Management Pharmacy Technician 52

European Pharmaceutical Review

JANUARY 12, 2024

Prior to joining Clarivate, Levy held several roles in the pharmaceutical industry, including at Veeva Systems, Pharmaceutical Product Development (PPD) and Accenture. In these cases, AI can be used to identify mistakes/discrepancies in data and notify the physician.

Drug Development 78

Drug Development Pharmaceutical Companies Pharmaceutical Companies 78

ALiEM - Pharm Pearls

OCTOBER 30, 2023

The process of coaching often unlocks previously untapped sources of imagination, productivity and leadership.” The most supportive data for coaching in medicine is for physician wellness and mitigating burnout [7]. Impact of coaching on physician wellness: A systematic review. 2021; 43(10):1210-1213.

Communication 161

Communication 161

pharmaphorum

APRIL 12, 2022

But who does pharma need to reach to ensure these connections translate to increased knowledge and utilisation of its products? “But it’s not as if we’re getting tons more physicians coming into the market. “That aligns very well with including the direct care providers who are not physicians.

Communication 98

Communication 98

pharmaphorum

APRIL 21, 2022

In recent years, pharma has transformed its view of patients, from end-users of products to an integral part of the drug development pathway. Engagement is having a question to ask or a product to validate. This is a huge change management effort that requires us to work on our processes, our technologies, our data – everything.

Documentation 97

Documentation Drug Development 97

pharmaphorum

SEPTEMBER 25, 2020

Earlier this year, P360 launched its industry first IoT product Swittons as a platform for life sciences digital transformation initiatives. By integrating with existing systems and collecting data from sources across the enterprise, Swittons help automate messaging and other functions by utilizing push/pull data streams.

Communication 45

Communication 45

Pharma Marketing Network

AUGUST 31, 2022

The effectiveness of video lie within the data. Optinmonster reports 72% of customers would rather learn about a product or service by way of video. One ideal way is through video because you give viewers a total view of your company, highlighting your product or service and your value proposition.

52

52

European Pharmaceutical Review

DECEMBER 6, 2022

Most manufacturers were successful in their AAP application, with the HAS acknowledging most products met all three major criteria” In the first seven months since this reform, July 2021 to February 2022, 17 new product applications were submitted for an autorisation d’accès précoce (AAP, which includes the previous cohort ATU).

Chemotherapy 81

Chemotherapy 81

pharmaphorum

AUGUST 11, 2022

Next, pharmacists review the participant’s genetic results – along with health data such as drug, lifestyle, and food interactions – to customize a “Medication Action Plan” that members’ physicians can access to determine which drugs should be prescribed to increase safety and efficacy.

Dosage 94

Dosage Labelling 94

pharmaphorum

FEBRUARY 2, 2021

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. The webinar will also cover: Harnessing the UK’s linked-up data systems. Increasing patient access to clinical trials.

Diabetes 58

Diabetes 58

pharmaphorum

DECEMBER 15, 2022

Social media has become an important way for HCPs to exchange ideas, information, and questions, and to learn about new products and emerging data. These DOLs can be anyone, from physicians, nurses, pharmacists, allied health professionals, and researchers to patients, caregivers, journalists, and science writers.

Communication 92

Communication Vaccines 92

pharmaphorum

AUGUST 4, 2020

Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled trials, the use of surrogate endpoints, and the lack of active drug comparators. Scotland had the highest rate of non-approval for orphan drugs.

Labelling 111

Labelling 111

Viseven

MAY 15, 2023

On the contrary, search engines and social media provided healthcare professionals (HCPs) with more information about products and trends in the pharmaceutical industry and made them fastidious. Traditional detailing is a face-to-face demonstration of pharmaceutical products and services by sales representatives to healthcare professionals.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

ID Stewardship

JUNE 1, 2023

This includes making data accessible and communicating best practices. Can you explain why it is so exciting to have Firstline helping to support production of a city-wide antibiogram? But we are also aiming to stratify antibiogram data to make it relevant and useful for frontline clinicians as well.

Hospitals 52

Hospitals Nursing Homes Communication Medical Schools 52

pharmaphorum

SEPTEMBER 28, 2021

Not only can sales teams easily deliver much-needed information to HCPs and their staff, they can also obtain marketing data that makes future engagements more meaningful. Although an integral part of a physician’s work, she noted that the process of accessing or contacting reps can be very frustrating. For more about P360, visit P360.com.

Communication 52

Communication 52

Eye on FDA

JANUARY 9, 2022

Back in 2009 you may recall that FDA issued 45 Untitled Letters aimed at 14 companies regarding the use of banner ads/sponsored links where clearly benefits of a branded product were available, but risk information only ascertainable by clicking on a link. The Substance: What triggered the enforcement actions? Why This is a Fail.

Communication 64

Communication Documentation Labelling Pharmaceutical Companies 64

PharmaState Academy

AUGUST 9, 2023

Medico-marketing copy is aimed at doctors who need in-depth information about the product’s medical benefits, clinical studies, and safety profiles. FMCG copy, on the other hand, deals with everyday consumer products, which are less technical and require a simpler, more accessible language. Let us now discuss a few styles.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes 52

pharmaphorum

FEBRUARY 23, 2021

Early in 2020 a law was passed in Germany which reaffirmed the ability of Gemeinsame Bundesausschuss (G-BA), the Federal Joint Committee, to require the collection of Real World Evidence (RWE) from launch for Advanced Therapy Medicinal Products (ATMPs). Source: Data from Neil Grubert on LinkedIn. Tougher pricing? About the author.

Biosimilars 73

Biosimilars Medical Records 73

Safe Biologics

SEPTEMBER 12, 2023

View the full webinar here or watch individual segments linked below. Department of Health and Human Services​ View Mr. Reilly, Mr. Barker, and Mr. Clapton’s segment here. View Mr. Potts’ segment here. View Mr. Spiegel’s segment here. View the panel discussion here.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Board Vitals - Pharmacist

OCTOBER 2, 2022

As part of the NCCPA’s certification maintenance process, PA-C designees must pass the Physician Assistant National Recertifying Exam (PANRE) by the end of the tenth year of their certification maintenance cycle. Rosh Review is a leading provider of board review question bank products across a number of specialties. Progress Tracker.

Customer Service 52

Customer Service 52

FDA Law Blog: Biosimilars

JUNE 22, 2023

There are several factors that increase the difficulty of obtaining an OTC home clearance or authorization for an IVD, as opposed to a test that is done in a clinic following a physician order. In considering OTC IVDs and home collection devices, FDA needs to give more weight to the benefits of these products. seeking treatment).

Labelling 59

Labelling Hospitals 59

pharmaphorum

OCTOBER 7, 2020

Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. But according to OpenData’s general manager Rebecca Silver, the industry is often challenged with having accurate data on the doctors and the organisations they work for.

Pharmaceutical Companies 140

Pharmaceutical Companies Pharmaceutical Companies Hospitals 140

Safe Biologics

MAY 10, 2024

In response, ASBM Executive Director Michael Reilly published a blog post sharing his concerns with the Administration’s proposal to permit widespread automatic (pharmacy-level) substitution of all biosimilars in place of their reference products; without physician approval or FDA evaluation as current law requires. physicians.

Biosimilars 130

Biosimilars Drug Pricing Documentation Labelling 130

pharmaphorum

SEPTEMBER 9, 2021

Many patients and healthcare providers now meet online, and some clinical studies can be conducted virtually, with wearables and AI enabling data collection and treatment adaptation. The pandemic accelerated trends like digitisation , remote healthcare and the use of simpler care pathways. Telemedicine came to the fore.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

SEPTEMBER 22, 2020

Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . For example, BirdzAI’s churn forecasting capabilities puts predictive forecasting for physician prescriptions directly in the hands of company representatives.

65

65

European Pharmaceutical Review

SEPTEMBER 29, 2023

of the draft revised Community Code provides a reduction in the basic data exclusivity period for innovative medicinal products from eight to six years, a revision which did not come as a great surprise to many. However, in reality it would be challenging for any single application to benefit from all data exclusivity opportunities.

Communication 85

Communication Hospitals Vaccines 85

pharmaphorum

APRIL 22, 2021

Anne Kerber, VP, Head of Clinical Development, Europe at Kite, a Gilead Company, explains how the company works with researchers and physicians across Europe to expand patient access to cell therapy. This thought leadership series has been paid and developed by Kite, a Gilead Company. A collaborative approach to meet patient needs.

Immunity 98

Immunity Immunization Hospitals 98

The Nontraditional Pharmacist

NOVEMBER 20, 2019

Please understand that we have experience with all of these products, and we recommend them because they are helpful and useful, not because of the small commissions we make if you decide to buy something. Please do not spend any money on these products unless you feel you need them or that they will help you achieve your goals.

Communication 52

Communication Drug Pricing 52

The Physician Pharmacist

OCTOBER 19, 2023

️ Join us for an inspiring and informative Episode 6 of The Physician Pharmacist Podcast, where we have the privilege of sitting down with Dr. Brandon J. Smith, a newly appointed Infectious Disease Attending Physician. Visit The Physician Pharmacist Podcast for a list of episodes. Enjoying the podcast and want to listen to more?

Medical Schools 52

Medical Schools Hospitals Inpatient Pharmacy Technician 52